Hyfusin Group Holdings Limited (8512.HK)
HKD 0.24
(0.0%)
HKD 0.24
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 866.25 Million HKD | 26.47% |
| 2022 | 684.94 Million HKD | -15.97% |
| 2021 | 815.14 Million HKD | 46.63% |
| 2020 | 555.91 Million HKD | 80.76% |
| 2019 | 307.54 Million HKD | 42.76% |
| 2018 | 215.43 Million HKD | 32.55% |
| 2017 | 162.52 Million HKD | 2.58% |
| 2016 | 158.43 Million HKD | 8.51% |
| 2015 | 146 Million HKD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 203.11 Million HKD | 0.0% |
| 2024 Q1 | 203.11 Million HKD | -58.96% |
| 2023 FY | 866.25 Million HKD | 26.47% |
| 2023 Q4 | 494.9 Million HKD | 55.78% |
| 2023 Q1 | 147.14 Million HKD | -8.62% |
| 2023 Q2 | 224.2 Million HKD | 52.37% |
| 2023 Q3 | 317.69 Million HKD | 41.7% |
| 2022 Q1 | 155.28 Million HKD | -31.47% |
| 2022 FY | 684.94 Million HKD | -15.97% |
| 2022 Q4 | 161.02 Million HKD | -12.77% |
| 2022 Q3 | 184.61 Million HKD | 0.32% |
| 2022 Q2 | 184.02 Million HKD | 18.51% |
| 2021 Q1 | 139.53 Million HKD | -39.55% |
| 2021 Q2 | 199.5 Million HKD | 42.98% |
| 2021 Q3 | 249.51 Million HKD | 25.06% |
| 2021 Q4 | 226.59 Million HKD | -9.19% |
| 2021 FY | 815.14 Million HKD | 46.63% |
| 2020 Q2 | 69.49 Million HKD | -11.82% |
| 2020 Q1 | 78.81 Million HKD | -17.04% |
| 2020 Q3 | 176.8 Million HKD | 154.4% |
| 2020 Q4 | 230.8 Million HKD | 30.55% |
| 2020 FY | 555.91 Million HKD | 80.76% |
| 2019 Q4 | 94.99 Million HKD | -15.84% |
| 2019 FY | 307.54 Million HKD | 42.76% |
| 2019 Q3 | 112.87 Million HKD | 133.56% |
| 2019 Q2 | 48.32 Million HKD | -5.89% |
| 2019 Q1 | 51.35 Million HKD | -13.66% |
| 2018 Q3 | 68.1 Million HKD | 42.74% |
| 2018 Q1 | 40.13 Million HKD | 5.33% |
| 2018 Q4 | 59.47 Million HKD | -12.67% |
| 2018 FY | 215.43 Million HKD | 32.55% |
| 2018 Q2 | 47.71 Million HKD | 18.87% |
| 2017 Q3 | 69.28 Million HKD | 96.65% |
| 2017 Q1 | 27.56 Million HKD | 0.0% |
| 2017 Q2 | 35.23 Million HKD | 27.82% |
| 2017 Q4 | 38.1 Million HKD | -45.0% |
| 2017 FY | 162.52 Million HKD | 2.58% |
| 2016 FY | 158.43 Million HKD | 8.51% |
| 2015 FY | 146 Million HKD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 336.01 Million HKD | -157.801% |
| Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -13038.95% |
| China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -378.605% |
| Prosperous Future Holdings Limited | 470.33 Million HKD | -84.179% |
| Huasheng International Holding Limited | 565.9 Million HKD | -53.073% |
| Fourace Industries Group Holdings Limited | 268.02 Million HKD | -223.199% |
| Evergreen Products Group Limited | 979.24 Million HKD | 11.538% |
| EC Healthcare | 4.21 Billion HKD | 79.429% |
| Ming Fai International Holdings Limited | 2.06 Billion HKD | 58.097% |
| Blue Moon Group Holdings Limited | 7.32 Billion HKD | 88.172% |
| SuperRobotics Holdings Limited | 15.08 Million HKD | -5643.989% |
| Takbo Group Holdings Limited | 215.59 Million HKD | -301.803% |